Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-09 Sale | 2024-02-09 8:59 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 45,000 | $29.9 | $1,345,500 | 2,139,882 (Direct) | View |
| 2024-02-08 Sale | 2024-02-08 7:40 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 269,079 | $26.87 | $7,230,784 | 2,184,882 (Direct) | View |
| 2024-02-08 Sale | 2024-02-08 7:38 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $28.05 | $701,250 | 0 (Direct) | View |
| 2024-01-31 Sale | 2024-01-31 8:39 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 85,000 | $24.71 | $2,100,750 | 2,279,030 (Direct) | View |
| 2024-01-30 Sale | 2024-01-30 9:05 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $23.95 | $838,250 | 2,364,030 (Direct) | View |
| 2024-01-19 Sale | 2024-01-19 8:35 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $23.05 | $691,500 | 25,000 (Direct) | View |
| 2024-01-04 Sale | 2024-01-04 9:35 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 15,000 | $17.9 | $268,500 | 335,730 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:31 pm | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 40,000 | $25 | $1,000,000 | 30,000 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:30 pm | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $24 | $384,000 | 47,965 (Direct) | View |
| 2023-05-01 Sale | 2023-05-01 7:03 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 45,000 | $22.45 | $1,010,250 | 2,197,963 (Direct) | View |
| 2023-04-24 Sale | 2023-04-24 7:31 pm | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $22 | $352,061 | 47,965 (Direct) | View |
| 2023-04-19 Sale | 2023-04-21 7:29 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $21.45 | $750,750 | 2,242,963 (Direct) | View |
| 2023-04-17 Sale | 2023-04-18 7:10 pm | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 20,786 | $20 | $415,720 | 47,965 (Direct) | View |
| 2023-04-17 Sale | 2023-04-18 7:09 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 155,000 | $20.45 | $3,169,766 | 2,277,963 (Direct) | View |
| 2023-04-17 Sale | 2023-04-18 7:08 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 12,500 | $20 | $250,000 | 287,763 (Direct) | View |
| 2023-04-17 Sale | 2023-04-18 7:07 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $20 | $150,000 | 149,279 (Direct) | View |
| 2023-04-13 Sale | 2023-04-13 5:14 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 79,336 | $18.45 | $1,463,749 | 2,307,963 (Direct) | View |
| 2023-04-11 Sale | 2023-04-13 5:13 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 97,839 | $18 | $1,761,310 | 366,823 (Direct) | View |
| 2023-03-30 Sale | 2023-04-03 7:26 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 243,352 | $17.31 | $4,211,292 | 2,535,081 (Direct) | View |
| 2023-03-30 Sale | 2023-04-03 7:24 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 161,940 | $17.19 | $2,784,219 | 149,279 (Direct) | View |
| 2023-03-28 Sale | 2023-03-30 9:04 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 237,805 | $15.17 | $3,608,317 | 261,895 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-27 Option Award | 2024-03-27 8:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 31,667 | $0 | 363,565 (Direct) | View |
| 2024-03-27 Tax Withholding | 2024-03-27 8:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 16,610 | $83.34 | 363,565 (Direct) | View |
| 2024-03-27 Option Award | 2024-03-27 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 221,667 | $0 | 2,266,453 (Direct) | View |
| 2024-03-27 Tax Withholding | 2024-03-27 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 153,948 | $83.34 | 2,266,453 (Direct) | View |
| 2024-03-27 Option Award | 2024-03-27 8:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 31,667 | $0 | 207,361 (Direct) | View |
| 2024-03-27 Tax Withholding | 2024-03-27 8:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 16,610 | $83.34 | 207,361 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 7:54 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 162,815 | $85.22 | 2,198,734 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 7:54 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 221,667 | $0 | 2,198,734 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 7:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 16,958 | $85.22 | 348,508 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 7:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 31,667 | $0 | 348,508 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 7:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 20,093 | $85.22 | 192,304 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 7:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 31,667 | $0 | 192,304 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-08 7:40 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 140,000 | $4.65 | 2,184,882 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-08 7:40 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 49,079 | $1.23 | 2,184,882 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-08 7:40 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 189,079 | $0 | 2,184,882 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-08 7:38 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $8.32 | 0 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-08 7:38 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $0 | 0 (Direct) | View |
| 2024-01-31 Exercise | 2024-01-31 8:39 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 85,000 | $1.23 | 2,279,030 (Direct) | View |
| 2024-01-31 Exercise | 2024-01-31 8:39 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 85,000 | $0 | 2,279,030 (Direct) | View |
| 2024-01-30 Exercise | 2024-01-30 9:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $1.23 | 2,364,030 (Direct) | View |
| 2024-01-30 Exercise | 2024-01-30 9:05 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $0 | 2,364,030 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-19 8:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $8.32 | 25,000 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-19 8:35 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $0 | 25,000 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-04 9:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 214,640 | $17.4 | 2,624,882 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-04 9:37 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 670,000 | $0 | 2,624,882 (Direct) | View |
| 2024-01-04 Tax Withholding | 2024-01-04 9:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 39,552 | $18.58 | 2,624,882 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-04 9:36 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 49,210 | $17.4 | 488,799 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-04 9:36 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 253,334 | $0 | 488,799 (Direct) | View |
| 2024-01-04 Tax Withholding | 2024-01-04 9:36 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 14,199 | $18.58 | 488,799 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-04 9:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 49,122 | $17.4 | 335,730 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-04 9:35 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 253,334 | $0 | 335,730 (Direct) | View |
| 2024-01-04 Tax Withholding | 2024-01-04 9:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 13,872 | $18.58 | 335,730 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 9:28 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 9:27 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 9:25 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 9:24 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 9:22 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 6:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 40,000 | $1.08 | 30,000 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 6:31 pm | 2018-07-01 2027-07-01 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 40,000 | $0 | 30,000 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 6:30 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $1.19 | 47,965 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 6:30 pm | 2018-01-03 2027-01-03 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $0 | 47,965 (Direct) | View |
| 2023-04-24 Exercise | 2023-04-24 7:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $3.33 | 47,965 (Direct) | View |
| 2023-04-24 Exercise | 2023-04-24 7:31 pm | 2017-01-04 2026-01-04 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $0 | 47,965 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:10 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 20,786 | $8 | 47,965 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:10 pm | 2016-05-26 2025-04-28 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 20,786 | $0 | 47,965 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:09 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 125,000 | $2.15 | 2,277,963 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:09 pm | 2017-03-04 2026-03-04 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 125,000 | $0 | 2,277,963 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:08 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 12,500 | $13.07 | 287,763 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:08 pm | 2018-08-31 2018-08-31 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 12,500 | $0 | 287,763 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:07 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $13.07 | 149,279 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:07 pm | 2018-08-31 2028-08-31 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $0 | 149,279 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-13 5:14 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 54,336 | $1.88 | 2,307,963 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-13 5:14 pm | 2016-03-14 2026-03-14 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 54,336 | $0 | 2,307,963 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 30,000 | $4.88 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,339 | $7.77 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 52,000 | $5.8 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 97,839 | $0 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 8,500 | $4.68 | 366,823 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-03 7:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 200,000 | $17.57 | 2,535,081 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 115,852 | $1.23 | 2,535,081 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 87,500 | $9.49 | 2,535,081 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-03 7:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 300,000 | $0 | 2,535,081 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:26 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 203,352 | $0 | 2,535,081 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 12,250 | $4.65 | 149,279 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 30,911 | $7.77 | 149,279 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 55,166 | $17.57 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 32,000 | $8.52 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 42,000 | $7.69 | 149,279 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 56,667 | $0 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | 2020-01-15 2029-01-15 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 124,661 | $0 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $4.12 | 149,279 (Direct) | View |
| 2023-03-30 Tax Withholding | 2023-04-03 7:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 30,799 | $17.57 | 288,763 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 23,100 | $8.52 | 288,763 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 36,100 | $17.01 | 288,763 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 10,000 | $7.69 | 288,763 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 3,000 | $6.47 | 288,763 (Direct) | View |
| 2023-03-30 Option Award | 2023-04-03 7:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 56,667 | $0 | 288,763 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:22 pm | 2020-01-15 2029-01-15 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 36,100 | $0 | 288,763 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 24,500 | $4.65 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 15,000 | $1.26 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 15,000 | $1.08 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 10,000 | $1.04 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 4,873 | $1.88 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 53,054 | $1.23 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 30,000 | $4.37 | 261,895 (Direct) | View |
| 2023-03-29 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 15,000 | $9.13 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 15,000 | $2.15 | 261,895 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-30 9:04 pm | 2017-03-04 2026-03-04 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 182,427 | $0 | 261,895 (Direct) | View |
| 2023-01-15 Tax Withholding | 2023-01-17 7:39 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 1,079 | $8.95 | 317,273 (Direct) | View |
| 2023-01-04 Tax Withholding | 2023-01-04 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 20,708 | $8.42 | 389,057 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-04 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 23,933 | $8.52 | 389,057 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 6:25 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 314,900 | $0 | 389,057 (Direct) | View |
| 2022-12-30 Tax Withholding | 2023-01-04 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 19,697 | $9.4 | 389,057 (Direct) | View |
| 2023-01-04 Tax Withholding | 2023-01-04 6:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 13,994 | $8.42 | 522,352 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-04 6:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 18,854 | $8.52 | 522,352 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 6:24 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 318,167 | $0 | 522,352 (Direct) | View |
| 2022-12-30 Tax Withholding | 2023-01-04 6:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 12,773 | $9.4 | 522,352 (Direct) | View |
| 2023-01-04 Tax Withholding | 2023-01-04 6:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 28,619 | $8.42 | 2,872,963 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-04 6:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 68,252 | $8.52 | 2,872,963 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 6:24 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 988,334 | $0 | 2,872,963 (Direct) | View |
| 2022-12-30 Tax Withholding | 2023-01-04 6:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 66,127 | $9.4 | 2,872,963 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 6:13 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 22,000 | $0 | 22,000 (Direct) | View |